Actemra Approved for Rheumatoid Arthritis
Links shared publicly online about this topic
FDA Approves Actemra for Treatment of Rheumatoid Arthritis
emaxhealth.com — “Yesterday, Genetech Inc (a subsidiary of the Roche Group) announced that the U.S. Food and Drug Administration (FDA) has approved Actemra (tocilizuma...” View full resource at emaxhealth.com
Most Recently Shared on January 9, 2010 at 7:00 pm By:
Dr. Kevin Smith Doctor, CAM, and Chiropractor
FDA Approves Actemra for Treatment of Rheumatoid Arthritis ...: Yesterday, Genetech Inc (a subsidiary of the Ro.. http://bit.ly/5oOGXA
Actemra « Rheumatoid Arthritis Guy
rheumatoidarthritisguy.com — “Actemra « Rheumatoid Arthritis Guy” View full resource at rheumatoidarthritisguy.com
Most Recently Shared on January 9, 2010 at 5:07 am By:
U.S. approves Roche’s Actemra arthritis drug http://bit.ly/8kbo6u
ACTEMRA (tocilizumab) | Rheumatoid Arthritis Treatment
actemra.com — “Find information about ACTEMRA, an FDA-approved treatment for rheumatoid arthritis. ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor inhibitor. ACTEMRA is used to treat adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a Tumor Necrosis Factor (TNF) antagonist has been used and did not work well. ACTEMRA is used to treat people with active systemic juvenile idiopathic arthritis (SJIA) 2 years of age and older. So” View full resource at actemra.com
Most Recently Shared on January 20, 2012 at 3:35 pm By:
FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
drugs.com — “Actemra (tocilizumab) is used to treat rheumatoid arthritis. Includes Actemra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on January 12, 2010 at 12:27 am By:
FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis - http://bit.ly/8vWion
FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
drugs.com — “Actemra (tocilizumab) is used to treat Rheumatoid Arthritis and Systemic Juvenile Idiopathic Arthritis . Includes Actemra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 19, 2011 at 3:15 am By:
FDA Approves Actemra for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA) - http://bit.ly/gKMQJR
Medicine and Technology [part of HCPLive]: FDA approves Actemra (tocilizumab) for rheumatoid arthritis
medicineandtechnology.com — “Medicine and Technology [part of HCPLive]: FDA approves Actemra (tocilizumab) for rheumatoid arthritis” View full resource at medicineandtechnology.com
Most Recently Shared on January 12, 2010 at 4:19 am By:
Joseph Kim, MD, MPH Doctor and Physician
FDA approves Actemra (tocilizumab) for rheumatoid arthritis http://bit.ly/5xmlaz
Actemra approved for moderately to severely active rheumatoid arthritis - MPR
empr.com — “The FDA has approved Actemra (tocilizumab, from Roche) for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.” View full resource at empr.com
Most Recently Shared on January 11, 2010 at 3:00 pm By:
MPR News: Actemra approved for moderately to severely active rheumatoid arthritis: The FDA has approved Actemra (t... http://bit.ly/8WioYm
FDA Approves ACTEMRA(R) (tocilizumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis
medicalnewstoday.com — “Genentech, inc., a wholly owned member of the roche group (six: ro, rog; otcqx: rhhby), today announced that the u.s. food and drug administration (fda) approved actemra® (tocilizumab) for the” View full resource at medicalnewstoday.com
Most Recently Shared on January 11, 2010 at 5:07 pm By:
MNT Arthritis News Health News
FDA Approves ACTEMRA(R) (tocilizumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis http://mnt.to/3w8r
FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
drugs.com — “Actemra (tocilizumab) is used to treat Rheumatoid Arthritis and Systemic Juvenile Idiopathic Arthritis . Includes Actemra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 19, 2011 at 4:12 am By:
Drugs and Devices OW OW Health
FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA): SOU... http://bit.ly/h7x9uE #drug
FDA Grants Supplemental Approval for Actemra (tocilizumab)
drugs.com — “Actemra (tocilizumab) is used to treat rheumatoid arthritis. Includes Actemra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on January 8, 2011 at 7:10 am By:
Drugs and Devices OW OW Health
FDA Grants Supplemental Approval for Actemra (tocilizumab): SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--... http://bit.ly/hYVEcs #drug
Actemra gains indication for inhibition and improvement of RA - ONA
oncologynurseadvisor.com — “Genentech announced that the FDA has approved Actemra (tocilizumab injection) for the inhibition and slowing of structural joint damage, improvement of physical function, and achievement of major clinical response in adult patients with moderately to severely active rheumatoid arthritis (RA), when given in combination with methotrexate (MTX).” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 5, 2011 at 6:06 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Actemra gains indication for inhibition and improvement of RA http://goo.gl/fb/2cR3d
Actemra gains indication for inhibition and improvement of RA - MPR
empr.com — “Genentech announced that the FDA has approved Actemra (tocilizumab injection) for the inhibition and slowing of structural joint damage, improvement of physical function, and achievement of major clinical response in adult patients with moderately to severely active rheumatoid arthritis (RA), when given in combination with methotrexate (MTX).” View full resource at empr.com
Most Recently Shared on January 5, 2011 at 6:12 pm By:
MPR News: Actemra gains indication for inhibition and improvement of RA: Genentech announced that the FDA has ap... http://bit.ly/ebgisU
Actemra Gains Approval for Systemic Juvenile Idiopathic Arthritis - ONA
oncologynurseadvisor.com — “The FDA has approved Actemra (tocilizumab; Genentech), given alone or in combination with methotrexate, for the treatment of active systemic juvenile idiopathic arthritis (SJIA), or Still--™s disease, in children 2 years.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 18, 2011 at 4:12 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Actemra Gains Approval for Systemic Juvenile Idiopathic Arthritis http://goo.gl/fb/Fz9Ea
Actemra Gains Approval for Systemic Juvenile Idiopathic Arthritis - MPR
empr.com — “The FDA has approved Actemra (tocilizumab; Genentech), given alone or in combination with methotrexate, for the treatment of active systemic juvenile idiopathic arthritis (SJIA), or Still--™s disease, in children 2 years.” View full resource at empr.com
Most Recently Shared on April 18, 2011 at 4:11 pm By:
MPR News: Actemra Gains Approval for Systemic Juvenile Idiopathic Arthritis: The FDA has approved Actemra (tocil... http://bit.ly/erCY89
FDA Approves ACTEMRA for the Treatment of Moderately to Severely Active Rheumatoid Arthritis | Pharmaceutical Processing
pharmpro.com — “Roche today announced that the FDA approved ACTEMRA (tocilizumab, RoACTEMRA in the European Union) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.” View full resource at pharmpro.com
Most Recently Shared on January 11, 2010 at 1:27 pm By:
RT @PharmProEditor: #FDA Approves ACTEMRA for the Treatment of Moderately to Severely Active Rheumatoid Arthritis http://bit.ly/5AiTH4
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Dr. Kevin Smith
I'm a doctor of chiropractic with a focus in spinal rehabilitation, brain based therapies and functional medicine. 412-212-8880
-
RA Guy
Adventures of a superhero on his journey through chronic pain and debilitating inflammation
-
Nicole Kinsey
I'm part of the OrganizedWisdom team, helping to curate and organize the best health, pet, environment, and healthy eating resources online! Adding more text.
I'm part of the OrganizedWisdom team, helping to curate and organize the best health, pet, environment, and healthy eating resources online! Adding more text.
I'm part of the OrganizedWisdom team, helping to curate and organize the best health, pet, environment, and healthy eating resources online! Adding more text.
I'm part of the OrganizedWisdom team, helping to curate and organize the best health, pet, environment, and healthy eating resources online! Adding more text.
Advertisement
